United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) is beginning to share intelligence with India in order to curb the unlicensed drugs in the country. UK officials believe that this information can assist the Indian Directorate Revenue...
India’s health ministry, the Central Drugs Standard Control Organization (CDSCO), has amended its Medical Devices Rules 2017 to simplify the approval process for in-vitro diagnostic (IVD) devices. All NABL-accredited labs will have the power to carry out...
Increased public concern on the quality of medicines marketed in India has prompted a conversation about the need for a technology to authenticate the drugs that are being sold. The authentication would take place for the top 300 pharmaceutical brands in the country...
In May, the Organization’s Drugs Technical Advisory Board approved a proposal to define implantable devices and high-end equipment under the list of medical products to be governed by the Drugs and Cosmetics Act, 1940. For now, these devices will be defined as...
As the demand for quality healthcare in East Asian countries skyrockets, so does the potential for astronomical growth for the pharmaceutical and medical device industries. While jumping into markets in that region can be tempting, it is important to note that...